"We are committed to the preservation and improvement of the health, welfare and performance of the fish," said Fernando Flores.

MSD Animal Health, a leading bio pharmaceutical company in the sector worldwide, once again reaffirms its commitment to science, research and the development of innovative solutions for the salmon industry, supporting as a sponsor Diamond, the Second Congress Impacts and Prevention and Control Strategies of Caligidosis in Chilean Salmon Farming, which will take place on Tuesday 22 and Wednesday 23 October in the Hotel Cumbres from the city of Puerto Varas, Los Lagos region.

An essential pillar of our work is to collaborate in the generation of spaces for exchange of scientific and technical knowledge where, together with academics, researchers, producers and suppliers, we can address the main Health challenges that confronts the salmon industry in the country, as is the case of caligidosis," he emphasized. Fernando Flores, who is Associate Director Sales Aqua of MSD Animal Health Chile.

In this line, he said: "We are committed to the preservation and improvement of the health, well-being and performance of fish and, therefore, We contribute permanently with instances like this, in addition to virtuous alliances with the academia that allow us to develop and deliver to our customers every day new tools that contribute to the sustainable growth of the sector".

The executive added that currently MSD Animal Health has a solid and complete portfolio of solutions for aquaculture, including antiparasitic treatments, vaccines, water supplements and nutrition, and varied technologies, in addition to wide capacities scientific and research that position the company favorably in the world aquaculture industry and allow it to deliver cutting-edge solutions.

Results

Organised by the Salmon Technological Institute (Intesal) from the Chilean Salmon Industry Association A.G. (SalmonChile)in conjunction with the Interdisciplinary Centre for Aquaculture Research (INCAR) and the Institute for Aquaculture and the Environment (IACUI) from the Austral University of Chile (University of Chile)the objective of the "Second Congress of Caligidosis" is to convene various experts and experts, research centers and academic institutions to present their studies in sea lice, promoting a active discussion and synergies on research and thus speed up the delivery of results to the main users (industry and state), in addition to identifying new lines study to solve the challenges posed by the parasite in salmon farming.

Read more » At the Caligidosis Congress: They will present Garware's innovative technology

The meeting will have two master lectures, one poster session and four thematic sessions focused on "Biology of Caligus and Host-Parasite Interaction", "Pharmacological Treatments, Sensitivity and Resistance", "Non-pharmacological Tools" and "Sustainability for the Prevention and Control of Caligidosis", where researchers and professionals from various companies, centers of studies and universities of the country will make their findings.

In this context, MSD Animal Health will present to the scientific community and aquaculture producers the conclusions of the study entitled "Development and validation of a bioassay to monitor the sensitivity of Caligus rogercresseyi to Lufenurón", led by the IACUI specialist, Sandra Marín; research that, while initiated in 2019, has just been completed and reports Interesting conclusions.

"The results to be released are one more sample of the Continuing commitment from MSD Animal Health with the salmon industry. As always, we will continue to collaborate with the academy to develop new solutions that support the development of salmon farming and that promote science, research and innovation in the sector", concluded Fernando Flores.

* Credits from the featured photo: courtesy of MSD.